Generate a tailored SOP for Dr. Manny Papadimitropoulos. Improve your application with a focused, well-structured draft.
Manny Papadimitropoulos leads research focused on health outcomes evaluation, collaborating with clinical teams to enhance the design of randomized clinical trials and ensure comprehensive data collection. His research addresses the complexities of healthcare financing and informs policymakers on effective resource allocation. His work involves evaluating the cost-effectiveness of various interventions across different disease states, with a specific focus on the quality of life impacts for patients. Notably, his team has investigated the healthcare outcomes for solid organ transplant patients and explored pharmacogenetic technologies to optimize treatments for stroke patients. As a Health Technology Assessment Scientific Leader for Latin America at Eli Lilly, he contributes to advancing pharmaceutical interventions to improve patient care.
Eli Lilly Canada Inc. • Scarborough, Canada
Leading health outcomes evaluation research and guiding clinical quality assessments for new drug interventions.
Department of Sociology